相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
该BioSIM 抗人 CD140b/PDGFRB 抗体,生物类似药,科研用途的免疫原请参考该产品的说明书
- 保存条件:
为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。
- 克隆性:
单克隆
- 适应物种:
Human
- 保质期:
为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。
- 级别:
科研级别
- 库存:
999
- 供应商:
亚科因(Abbkine)
- 宿主:
Human
- 应用范围:
ELISA, FACS, Functional assay, Research in vivo
- 抗体英文名:
CD140b/PDGFRB
- 抗体名:
CD140b/PDGFRB
- 规格:
5mg
BioSIM 抗人 CD140b/PDGFRB 抗体 (IMC-2C5 生物类似药)
产品货号:SIM0804-5mg
规格:5mg
供应商:InvivoCrown
产品概述
BioSIM 抗人 CD140b/PDGFRB 抗体是一种高质量的重组生物类似抗体,专为科研用途设计。本产品是IMC-2C5的生物类似药,采用先进的体外无蛋白细胞培养技术在无动物成分的设施中生产,确保产品的一致性和可重复性。
产品特点
- 高纯度:经过多步骤纯化过程,包括Protein A或G色谱工艺
- 无动物成分:完全在无动物成分的设施中生产
- 高特异性:针对人源CD140b/PDGFRB靶点
- 多种应用:适用于ELISA、FACS、功能分析及体内研究
背景信息
CD140b/PDGFRB(血小板衍生生长因子受体β)是一种重要的细胞表面受体,在多种生理和病理过程中发挥关键作用。研究表明,该受体与年龄相关性黄斑变性和湿性黄斑变性等眼部疾病密切相关。本抗体为研究人员提供了一种可靠的工具,用于探索这些疾病的发病机制和潜在治疗方法。
产品应用
本抗体经过验证,适用于以下实验应用:
- ELISA:可用于检测和定量分析
- FACS:适用于细胞表面标记分析和流式细胞术
- 功能分析:可用于研究信号通路和细胞功能
- 体内研究:适用于动物模型研究
产品参数
| 产品类型 | 二抗 |
| 来源宿主 | Human |
| 反应性 | Human |
| 免疫原 | 请参考产品说明书 |
| 研究领域 | 年龄相关性黄斑变性,湿性黄斑变性 |
储存与稳定性
为确保产品的最佳性能和稳定性,请遵循以下储存建议:
- 短期储存(1-2周):4°C条件下保存
- 中期储存(最长12个月):-20°C条件下保存
- 长期储存:-80°C条件下保存
- 重要提示:避免反复冻融,建议分装保存
注意事项
本产品仅供科研使用,不得用于诊断或治疗目的。使用时请遵循实验室安全操作规程。有关免疫原和其他详细信息,请参考产品说明书。
注意:以上信息可能随着产品优化升级等因素产生变动,具体信息请咨询亚科因公司。

BioSIM Anti-Human CD140b/PDGFRB Antibody (IMC-2C5 Biosimilar)
Catalog Number:SIM0804-5mg
Specifications:5mg
Supplier:InvivoCrown
Product Overview
BioSIM Anti-Human CD140b/PDGFRB Antibody is a high-quality recombinant biosimilar antibody designed for research purposes. This product is a biosimilar of IMC-2C5, produced in animal-component-free facilities using advanced protein-free cell culture technology in vitro, ensuring product consistency and reproducibility.
Product Features
- High Purity:Purified through multiple steps, including Protein A or G chromatography
- Animal-Free:Produced completely in animal-component-free facilities
- High Specificity:Targeted against human CD140b/PDGFRB
- Multiple Applications:Suitable for ELISA, FACS, functional assays, and in vivo studies
Background Information
CD140b/PDGFRB (Platelet-Derived Growth Factor Receptor Beta) is an important cell surface receptor that plays a critical role in various physiological and pathological processes. Research indicates that this receptor is closely associated with ocular diseases such as age-related macular degeneration and wet macular degeneration. This antibody provides researchers with a reliable tool for exploring the pathogenesis and potential treatment methods for these diseases.
Product Applications
This antibody has been validated for the following experimental applications:
- ELISA:Can be used for detection and quantitative analysis
- FACS:Suitable for cell surface marker analysis and flow cytometry
- Functional Assays:Can be used for studying signaling pathways and cellular functions
- In Vivo Studies:Suitable for animal model research
Product Parameters
| Product Type | Secondary Antibody |
| Host Origin | Human |
| Reactivity | Human |
| Immunogen | Please refer to product manual |
| Research Areas | Age-related macular degeneration, Wet macular degeneration |
Storage and Stability
To ensure optimal performance and stability of the product, please follow the storage recommendations below:
- Short-term storage (1-2 weeks):Store at 4°C
- Medium-term storage (up to 12 months):Store at -20°C
- Long-term storage:Store at -80°C
- Important note:Avoid repeated freeze-thaw cycles, aliquot storage is recommended
Precautions
This product is for research use only and is not intended for diagnostic or therapeutic purposes. Please follow laboratory safety operating procedures when using. For information on immunogen and other details, please refer to the product manual.
Note: The above information may change due to factors such as product optimization and upgrades. For specific information, please consult Yaokein Company.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验
技术资料暂无技术资料 索取技术资料






